Sensing and bioimaging of lead ions in intracellular cancer cells and biomedical media using amine-functionalized silicon quantum dots fluorescent probe.

A novel amine-functionalized silica quantum dots (SiQDs) fluorescent nanoprobe was developed for sensing of lead concentration in water, plasma and cell lysate. In addition, the developed probe was utilized for bioimaging of intracellular lead ions in HT 29 cancer cells. The amine-functionalized nanoprobe exhibited fluorescence emission at 445 nm under excitation at 355 nm. Upon addition of lead ions, the fluorescence of SiQDs linearly enhanced from 50 ng/mL to 5 µg/mL and 50 ng/mL to 25 µg/mL for plasma and standard media, respectively. The synthesis and fabrication of this probe are simple and serves high sensitivity with a limit of detection down to around 20 ng/mL. In the presence of various molecular and ion interfering, reliable results are obtained, confirming the specificity of the nanoprobe for lead ion detection. Meanwhile, amine-functionalized SiQD-based nanoprobe exhibits excellent cell membrane-permeability and biocompatibility. Thus, this probe is utilized for lead tracing in HT 29 cancer live cells. Fluorescent microscopy results confirmed the attachment of the produced nanomaterials to the HT 29 cancer cells.

Hyaluronic acid-decorated liposomal nanoparticles for targeted delivery of 5-fluorouracil into HT-29 colorectal cancer cells.

The use of liposomes as drug carriers improves the therapeutic efficacy of anticancer drugs, while at the same time reducing side effects. Hyaluronic acid (HA) is recognized by the CD44 receptor, which is overexpressed in many cancer cells. In this study, we developed HA-modified liposomes encapsulating 5-fluorouracil (5-FU) and tested them against a CD44 expressing colorectal cell line (HT29) and a non-CD44 expressing hepatoma cell line. The average size of 5-FU-lipo and 5-FU-lipo-HA nanoparticles were 112 ± 28 and 144 ± 77 nm, respectively. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTT) assay showed selective cancer cell death depending on the CD44 expression in a time-dependent manner. Apoptosis assays and cell-cycle analysis indicated that G0/G1 arrest occurred. The colony formation study revealed that cells treated with 5-FU-lipo and 5-FU-lipo-HA had reduced colony formation. Quantitative reverse-transcription polymerase chain reaction study showed that the oncogenic messenger RNA and microRNA levels were significantly reduced in the 5-FU-lipo-HA-treated group, while tumor suppressors were increased in that group. We suggest that optimal targeted delivery and release of 5-FU into colorectal cancer cells, renders them susceptible to apoptosis, cell-cycle arrest, and decreased colony formation.